معرفی
Steven Simoens is a full professor at the KU Leuven Faculty of Pharmaceutical Sciences, specializing in Clinical Pharmacology and Pharmacotherapy. His research focuses on pharmacoeconomics, biosimilar medicines, market access, and health policy, with a particular emphasis on rare diseases and cost-effectiveness analysis.
- Active in projects like 'How to Sustain Market Access to Advanced Therapies?'
- Key collaborator in studies on biosimilar adoption barriers and value assessment
- Contributor to health economic evaluations of preventive policies in Flanders
His recent publications analyze topics such as compulsory licensing for drug pricing, air pollution mitigation, and real-world evidence applications in healthcare decision-making. He teaches courses including 'Health Economics' and leads the Leuven.IRD Institute for Rare Diseases.
۰مقاله منتشرشده
